Navigation Links
Otho S.A. Sprague Memorial Institute awards Rush $230,000 for childhood obesity prevention
Date:2/22/2008

Obesity is one of the greatest health risks for children in the United States and, unfortunately, its on the rise. According to the Centers for Disease Control and Prevention, the number of obese children in America has tripled since 1980. To help Rush University Medical Center more effectively address this preventable threat, The Otho S.A. Sprague Memorial Institute has awarded Rush University Medical Center a $230,000 grant to support a first-of-its-kind childhood obesity project at Rush.

Rush plans to use the grant to pilot an 18-month test program, A Combined Biomedical and Psychosocial Approach to Weight Management, led by Cathy Lynn Joyce, MD, PhD, assistant professor in the Department of Pediatrics. In collaboration with an interdisciplinary team, families with children whose weights are rising above the ideal body weight will be assisted in their goal of preventing childhood obesity.

The program will help physicians to better understand the complicated factors that lead to childhood obesity and to develop a concrete protocol for effective behavioral change focusing on the child and their family. Rush is the first medical center to implement a formalized program utilizing an interdisciplinary team of health care professionals coupled with direct family involvement.

In many health care settings, involvement of the family is implied, but not supported. Our goal is to provide assessments, interventions and tools for both the child and family, Joyce said.

The pilot program will run February 2008 through July 2009. The project team will enroll patients from pediatric and adolescent practices at Rush with an economically, racially, ethnically and religiously diverse population of families. The project aims to enroll at least 40 to 50 families, with staff tracking the progress of each patient and family for 12 months. The team from Rush will include pediatricians, nurses, nutrition and fitness specialists, social workers and
'/>"/>

Contact: Mary Ann Schultz
mary_ann_schultz@rush.edu
312-942-7816
Rush University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. MemorialCare Medical Centers CEO Barry Arbuckle Elected Chair of California Hospital Association
2. Sharp Memorial Hospital Achieves Highest Honor for Nursing Excellence
3. Northwestern Memorial HealthCare and Northwestern Memorial Foundation Elect New Members to Board of Directors
4. Northwestern Memorials Heart Center Pioneers Minimally Invasive Surgery That Corrects Irregular Heart Beat
5. Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery
6. ...And the Grand Prize Goes to... Lockport Memorial Hospital, Winner of Siemens National Win an MRI Contest
7. GREENGUARD 2008 Memorial Fellowship Winners Will Examine Design
8. A Fort Worth Couple Sues Huguley Memorial Medical Center
9. Pennsylvania Invests $13.4 Million to Kick Off Butler Memorial Hospital Expansion
10. Dr. Lewis Drusin receives American College of Physicians James D. Bruce Memorial Award
11. Coshocton County Memorial Hospital RNs to Strike Despite Hospitals Claim of Financial Hardship
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)..., July 25 /PRNewswire/ -- BeaconEquity.com announc...ng news today., Investors can view all of the dai...conEquity.com/m , Today,s Trade Alerts include: D...rook Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaMe... ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abaxis In...
(Date:7/25/2008)...Relationship Based on Significant Improvements in ... MDdatacor, Inc., a leader in health,care quality ...s, today,announced it has entered into a long-term...ort Wellmark,s Collaboration on Quality(SM) Incent...tion between Wellmark and,primary care clinicians ...
(Date:7/25/2008)...AD, Calif., July 25 /PRNewswire/ -- AutoGenomics, ...ion statement on Form S-1 with the,Securities and ...al public,offering of shares of its common stock. ..., all of which are expected to be offered by,AutoG...g, have not yet been,determined., J.P. Morgan Sec...
(Date:7/25/2008)... Whether you are an Olympian, Profe... there are Five Things You Need to Know about Hydr...C. Spine and Sports Center , ...- America,s premier athletes are heading to Beijin...g and sacrifice in the hopes of capturing an Olymp...
Breaking Medicine News(10 mins):Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
...ry Centre in Wishaw is recovering at home in North....coli O157 infection. The Craigneuk Nursery Cent...s have been reported. A NHS Lanarkshire, spokesm...ild's age or sex, said all staff and parents of ch...
...the 25 year mark and this year has been heralded a...ss to lifesaving treatments last year even in deve...eported declining HIV infection rates. However Bil...nce in Toronto this week said that current trends ...
...h is needed to to fill in the gaps in HIV vaccine ...tut Pasteur//, France, at the 16th International A... Barré-Sinoussi there have been 85 HIV vaccine tri... Yet we are no closer to finding out whether a pro...
... soft drinks of two multinational giants till a re...overnment for testing, Chief Minister Buddhadeb Bh...aken only after we receive the report," Bhattachar...sharp contrast to Kerala, another communist-ruled ...
Other Medicine News:Health News:Need for Change in Social Norms to Prevent Spread of HIV 2Health News:Need for Change in Social Norms to Prevent Spread of HIV 3
(Date:7/23/2008)...re/ -- The following was,released by the U.S. Depa...ber Smith, and Members of the Committee.,Thank you...ppeared before this Committee almost six months ag...alented and dedicated professionals,at the Justice...come to,appreciate that much more deeply their ser...
(Date:7/23/2008)...-- Dendreon Corporation,(Nasdaq: DNDN ) today ann...ring Committee (IDMC) to review in October 2008 th... the Company,s Phase 3 IMPACT (IMmunotherapy,for P...902B) clinical trial,of PROVENGE(R) (sipuleucel-T)... cellular immunotherapy for the treatment of advan...
(Date:7/22/2008)...in Medical, a leading innovator,of physiological m...tered,the clinical testing phase with its breakthr...ion. Today,s most common application for this,tech...l blood oxygenation,in the brain -- cerebral oxime...oing clinical study at the,Duke University Medical...
(Date:7/22/2008)...a Exhibits Excellent Drug-Like ...tiation of Phase II Clinical Trials -, RESEARCH T... BioPharma,Inc., a clinical stage company develop...diseases of the central nervous system, today anno...M) into Phase II trials for the,treatment of depre...
Breaking Medicine Technology:Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Nicotine addiction slashed in test of new cigarette smoking strategy 6279 1Nicotine addiction slashed in test of new cigarette smoking strategy 6279 2Nicotine addiction slashed in test of new cigarette smoking strategy 6279 3Synaptics SecurePad 28TM 29 Selected as CES Innovations 2008 Design and Engineering Award Honoree 1208 1Synaptics SecurePad 28TM 29 Selected as CES Innovations 2008 Design and Engineering Award Honoree 1208 2Synaptics SecurePad 28TM 29 Selected as CES Innovations 2008 Design and Engineering Award Honoree 1208 3Plastic Surgery Complications and Deaths are Rare Despite Highly Publicized Death of Donda West 6273 1Plastic Surgery Complications and Deaths are Rare Despite Highly Publicized Death of Donda West 6273 2Plastic Surgery Complications and Deaths are Rare Despite Highly Publicized Death of Donda West 6273 3Fortune 500 Executive Elected to AMA Board of Trustees 6267 1Fortune 500 Executive Elected to AMA Board of Trustees 6267 2
...%; mso-hyphenate: none">,BUDAPEST, Hungary, June, ...ands of patients with cancer from suffering,unnece...gress of,the European Association for Palliative C...ted whether this first in class novel,formulation ...duration of effect, mirroring the breakthrough pai...
...IMPAX Laboratories,Inc. (OTC:IPXL) today announce...company,s compound, IPX054, a combined immediate-,...oduct to be,marketed as VADOVA(TM), were presented...onal Congress of Parkinson,s Disease and,Movement ... poster,presentations will be available in the Inv...
Other Medicine Technology:Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 2Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 4Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 5Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 6IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders 2IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders 3IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders 4
... FoamWrap ACTION Elbow Wrap replaces messy taping ..., and others experiencing epicondylitis. Preferred...nd non-bulky fit. Two overlay straps allow you to ...m lining holds the Elbow Wrap comfortably in place...
The Bledsoe Extender Arm Brace is designed to handle post-op elbow arthroscopy, severe elbow strains and ligament trauma. The Bledsoe Extender Arm Brace should be used when limited R.O.M. or locked c
...s controlled stretch ankle support helps reduce sw... of motion. It is easy to apply - it slips on lik...es. It features bilateral spiral stays that move ...nd stability. This is an excellent support for li...
...s lightweight ankle splint may be used for either ... It is effective in stabilizing the ankle joint f...removal. The rigid pre-bent metal stays are adjus... The stays also help the splint control rotational...
Medicine Products: